Author Interviews, Critical Care - Intensive Care - ICUs, NEJM, Vitamin C / 15.06.2022
NEJM: Trial of IV Vitamin C for Septic ICU Patients
MedicalResearch.com Interview with:
François Lamontagne MD MSc (pharmacology) MSc (CEB)
Professor of Medicine at the Université de Sherbrooke
Endowed research chair on patient-centred research
Dr. Neill Adhikari MDCM, M.Sc.
Sunnybrook Research Institute and University of Toronto
Toronto, Canada
MedicalResearch.com: What is the background for this study?
Response: The use of intravenous vitamin C for sepsis has been a hot topic for a few years. It was biologically plausible that vitamin C could reduce organ injury and death by scavenging reactive oxygen species and modulating the immune response to sepsis. It also seemed like an intervention that would be reasonably easy to administer globally should it prove beneficial. On the other hand, no intervention is benign and every aspect of health care should be rigorously studied. Regarding vitamin C, there were strongly held opinions in both camps and this motivated us to design and conduct the LOVIT trial.
(more…)